Sitaglu Met 50/1000mg Tablet (28) – Dual-Action Control for Type 2 Diabetes
Sitaglu Met 50/1000mg Tablet (28) – Dual-Action Control for Type 2 Diabetes
Description
Sitaglu Met 50/1000mg Tablet – Powerful Combination Therapy for Blood Sugar Management
Sitaglu Met 50/1000mg Tablet combines sitagliptin 50mg and metformin hydrochloride 1000mg to provide effective dual-mechanism control for adults with type 2 diabetes. Sitagliptin, a DPP-4 inhibitor, enhances the body's natural incretin response to boost insulin release and reduce glucagon levels when needed, while metformin improves insulin sensitivity and decreases glucose production in the liver. Together, they deliver superior glycemic control, lowering both fasting and post-meal blood sugar levels for better HbA1c reduction.
This fixed-dose combination tablet simplifies treatment with twice-daily dosing, making it an excellent option for patients inadequately controlled on metformin alone or those seeking convenient combination therapy alongside diet and exercise under medical supervision.
